Hence, genetic polymorphism may impair function of molecules important for effective activity of anti-tumor response, such as CTLA-4; the SNPs of CTLA-4 and other immune checkpoints molecules have been studied in the context of variety types of cancers. The gene discussed is CTLA4; the disease is cancer.